Venus Remedies Limited has informed the Exchange regarding Appointment of Savita Gupta as Injdependent Director of the company w.e.f. December 29, 2026.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Venus Remedies Limited has announced the appointment of Savita Gupta as an Independent Director with effect from December 29, 2026. She was initially appointed as an Additional Director on December 29, 2025, and is being regularised for a 5-year term subject to shareholder approval at the 37th AGM on August 20, 2026. Savita Gupta holds a Ph.D. and has over 35 years of experience spanning R&D, academia, and pharmaceutical manufacturing. Notably, she is related to promoter family members including Mr. Pawan Chaudhary, Mr. Akshansh Chaudhary, Mr. Saransh Chaudhary, Mr. Peeyush Jain, and Mr. Ashutosh Jain. The company also reappointed Mr. Saransh Chaudhary (related to promoters) as an Additional Director/Independent Director, and appointed Dr. Gurminder Singh Bedi and Dr. (Mrs.) Saroj Aggarwal as Independent Directors, all subject to shareholder approval. The filing also includes the company's audited Q4 and full-year FY2026 financial results showing standalone net profit of Rs 99.31 crore (vs Rs 52.55 crore previous year) and consolidated net profit of Rs 102.80 crore, along with a recommended 100% dividend of Rs 10 per share.
The appointment of a related-party individual as an Independent Director raises governance concerns, as independence criteria may not be fully met. Investors should monitor this at the AGM. The underlying financial performance for FY2026 is strong with near-doubling of net profit.